Zepp Health Corp 20-F/A, filed May 21, 2025
Zepp Health Corp (ZEPP)
About this 20-F/A
Zepp Health Corp filed this 20-F/A on May 21, 2025, covering the fiscal year ended December 31, 2024.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
(Amendment No. 1)
(Mark One)
OR
For the fiscal year ended
OR
OR
Date of event requiring this shell company report
For the transition period from _________ to _________
Commission file number:
(Exact Name of Registrant as Specified in Its Charter)
N/A
(Translation of Registrant’s Name into English)
(Jurisdiction of Incorporation or Organization)
(Address of Principal Executive Offices)
Phone:
Email:
(Name, Telephone, Email and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of Each Class |
Trading Symbol(s) |
Name of Each Exchange on Which Registered |
Class A ordinary shares, par value US$0.0001 per shares** |
*Effective on September 16, 2024, the ratio of ADSs to our Class A ordinary shares was changed from one ADS representing four Class A ordinary shares to one ADS representing 16 Class A ordinary shares.
**Not for trading, but only in connection with the listing of the American depositary shares on the New York Stock Exchange.
Securities registered or to be registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:
None
(Title of Class)
Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report:
As of December 31, 2024, there were (i) Class A ordinary shares issued and outstanding, par value US$0.0001 per share (excluding the 3,892,844 Class A ordinary shares issued to the depositary bank for bulk issuance of ADSs reserved for future issuances upon the exercise or vesting of awards granted under the issuer’s share incentive plans and the 29,673,924 treasury shares in the form of ADSs that the issuer repurchased under its share repurchase program), and (ii) Class B ordinary shares issued and outstanding, par value US$0.0001 per share.
Indicate by check mark if the registrant is a
well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ¨ Yes
x
If this report is an annual or transition report,
indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934. ¨ Yes x
Note - Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.
Indicate by check mark whether the registrant:
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days. x
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ¨ | Accelerated filer ¨ | Emerging
growth company |
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. ¨
†The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
Indicate
by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the
registered public accounting firm that prepared or issued its audit report.
If securities are registered pursuant to Section 12(b) of
the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an
error to previously issued financial statements.
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ¨
Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:
| International Financial Reporting Standards as issued by the | Other ¨ | |
| International Accounting Standards Board ¨ |
If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. ¨ Item 17 ¨ Item 18
If this is an annual report, indicate by check
mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. ¨ Yes ¨ No
Auditor Name |
Auditor Location |
Auditor Firm ID |
EXPLANATORY NOTE
This Amendment No. 1 on Form 20-F/A (the “Amendment”) is being filed by Zepp Health Corporation (the “Company,” “we,” “our,” or “us”) to amend the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2024, originally filed with the U.S. Securities Exchange Commission on April 25, 2025 (the “Original Filing”). This Amendment is being filed for the purpose of complying with Regulation S-X, Rule 3-09. Rule 3-09 requires, among other things, that separate financial statements for unconsolidated subsidiaries and investees accounted for by the equity method to be included in the Form 20-F when such entities are individually significant.
We have determined that our equity method investment in Jiangsu Yitong High-tech Co., Ltd. (hereinafter referred to as “Jiangsu Yitong”), which is not consolidated in our financial statements, was significant under the investment test of Rule 1-02(w) of Regulation S-X in relation to our financial results for the year ended December 31, 2024. This Amendment is therefore filed to supplement the Original Filing with the inclusion of the financial statements and related notes of Jiangsu Yitong as of December 31, 2023 and 2024 and for the fiscal years ended December 31, 2022, 2023 and 2024 (the “Jiangsu Yitong Financial Statements”).
This Form 20-F/A consists of the cover page, this explanatory note, the Jiangsu Yitong Financial Statements, updated certifications of our chief executive officer and chief financial officer, and consent of the independent auditor of Jiangsu Yitong. This Amendment does not affect any other parts of, or exhibits to, the Original Filing. Accordingly, this Amendment should be read in conjunction with the Original Filing and with our filings with the U.S. Securities Exchange Commission subsequent to the Original Filing.
TABLE OF CONTENTS
| PART III | 1 | ||
| ITEM 18. | FINANCIAL STATEMENTS | 1 | |
| ITEM 19. | EXHIBITS | 2 | |
i
PART III
| ITEM 18. | FINANCIAL STATEMENTS |
The following financial statements are included in this Form 20-F/A:
Consolidated financial statements of Jiangsu Yitong High-tech Co., Ltd. as of December 31, 2023 and 2024 and for the fiscal years ended December 31, 2022, 2023 and 2024.
1
JIANGSU YITONG HIGH-TECH CO., LTD
TABLE OF CONTENTS
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors of Jiangsu Yitong High-tech Co., Ltd
We have audited the accompanying consolidated balance sheets of Jiangsu Yitong High-tech Co., Ltd. and its subsidiaries (the “Company”) as of December 31, 2024 and 2023, the related consolidated statements of operations, changes in equity, and cash flows for the years ended December 31, 2024 and 2023, and the related notes.
Management’s Responsibility for the Consolidated Financial Statements
Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
Convenience translation
Our audit also comprehended the translation of Renminbi amounts into United States dollar amounts and, in our opinion, such translation has been made in conformity with the basis stated in Note 2 to the financial statements. Such United States dollar amounts are presented solely for the convenience of readers outside the People’s Republic of China.
Auditor’ Responsibility
Our responsibility is to express an opinion on the consolidated financial statements based on our audits. We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in consolidated financial statements. The procedures selected depend on our judgement, including the assessment of the risk of material misstatement of the consolidated financial statements, whether due to fraud or error. In making those risk assessments, we consider internal control relevant to the Company’s preparation and fair presentation of the consolidated financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
F-2
Opinion
In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for the years ended December 31, 2024 and 2023, in conformity with accounting principles generally accepted in the United States of America (“US GAAP”).
Other Matter
The accompanying consolidated statements of operations, of changes in equity and of cash flow of Jiangsu High-Tech Co., Ltd. and its subsidiaries for the year then ended December 31, 2022 are presented for purposes of complying with Rule 3-09 of SEC Regulation S-X; however, Rule 3-09 does not require the 2022 financial statements to be audited and they are therefore not covered by this report.
/s/ BROOK & PARTNERS CPAs
We have served as the Company’s auditor since 2023.
Beijing, the People’s Republic of China
May 21, 2025
F-3
JIANGSU YITONG HIGH-TECH CO., LTD
CONSOLIDATED BALANCE SHEETS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
| As of December 31, | ||||||||||||
| 2023 | 2024 | 2024 | ||||||||||
| RMB | RMB | US$ Note2 | ||||||||||
| ASSETS | ||||||||||||
| Current assets | ||||||||||||
| Cash and cash equivalents | 331,532 | 229,364 | 31,423 | |||||||||
| Restricted cash | 2,384 | 1,259 | 172 | |||||||||
| Notes receivable | 305 | 766 | 105 | |||||||||
| Accounts receivable, net (net of allowance of RMB3,884, RMB8,945 as of December 31, 2023 and 2024, respectively) | 21,315 | 121,488 | 16,644 | |||||||||
| Amounts due from related parties | 11,798 | 18,318 | 2,510 | |||||||||
| Inventories, net | 18,146 | 23,026 | 3,155 | |||||||||
| Installment payment receivables, net, current portion | 24,360 | 33,189 | 4,547 | |||||||||
| Contract assets | 399 | 6,598 | 904 | |||||||||
| Prepaid expenses and other current assets | 8,536 | 17,853 | 2,446 | |||||||||
| Total current assets | 418,775 | 451,861 | 61,906 | |||||||||
| Non-current assets | ||||||||||||
| Installment payment receivables, net | 41,455 | 22,387 | 3,067 | |||||||||
| Property and equipment, net | 84,052 | 74,170 | 10,161 | |||||||||
| Intangible assets, net | 40,700 | 45,735 | 6,266 | |||||||||
| Goodwill | - | 30,954 | 4,241 | |||||||||
| Deferred tax assets | 10,910 | 15,920 | 2,181 | |||||||||
| Operating lease right-of-use assets, net | 787 | 957 | 131 | |||||||||
| Other non-current assets | - | 4,225 | 579 | |||||||||
| Total non-current assets | 177,904 | 194,348 | 26,626 | |||||||||
| Total assets | 596,679 | 646,209 | 88,532 | |||||||||
F-4
JIANGSU YITONG HIGH-TECH CO., LTD
CONSOLIDATED BALANCE SHEETS - CONTINUED
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
| As of December 31, | ||||||||||||
| 2023 | 2024 | 2024 | ||||||||||
| RMB | RMB | US$ Note2 | ||||||||||
| LIABILITIES | ||||||||||||
| Current liabilities | ||||||||||||
| Short-term bank borrowing | - | 1,103 | 151 | |||||||||
| Notes payable | 7,758 | 4,009 | 549 | |||||||||
| Accounts payable | 14,858 | 49,094 | 6,726 | |||||||||
| Advance from customers | 3,375 | 3,998 | 548 | |||||||||
| Income tax payable | 1,349 | 4,163 | 570 | |||||||||
| Accrued expenses and other current liabilities | 13,143 | 26,055 | 3,572 | |||||||||
| Amounts due to related parties | 30,849 | 43,965 | 6,023 | |||||||||
| Total current liabilities | 71,332 | 132,387 | 18,139 | |||||||||
| Non-current liabilities | ||||||||||||
| Deferred revenue | 4,387 | 3,660 | 501 | |||||||||
| Amounts due to related parties, non-current | 294 | 22 | 3 | |||||||||
| Deferred tax liabilities | 289 | 264 | 36 | |||||||||
| Long-term bank borrowing | - | 8,898 | 1,219 | |||||||||
| Other non-current liabilities | - | 736 | 101 | |||||||||
| Total non-current liabilities | 4,970 | 13,580 | 1,860 | |||||||||
| Total liabilities | 76,302 | 145,967 | 19,999 | |||||||||
| Equity | ||||||||||||
| Ordinary shares | 303,907 | 303,930 | 41,638 | |||||||||
| Additional paid-in capital | 54,479 | 55,545 | 7,610 | |||||||||
| Accumulated retained earnings | 161,991 | 123,127 | 16,868 | |||||||||
| Total Jiangsu Yitong High-tech Co., Ltd shareholders’ equity | 520,377 | 482,602 | 66,116 | |||||||||
| Noncontrolling interest | - | 17,640 | 2,417 | |||||||||
| Total equity | 520,377 | 500,242 | 68,533 | |||||||||
| Total liabilities and equity | 596,679 | 646,209 | 88,532 | |||||||||
The accompanying notes are an integral part of these consolidated financial statements.
F-5
JIANGSU YITONG HIGH-TECH CO., LTD
CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
| For the year ended December 31, | ||||||||||||||||
| 2022 (Unaudited) |
2023 | 2024 | 2024 | |||||||||||||
| RMB | RMB | RMB | US$ Note2 | |||||||||||||
| Revenues (including RMB222,174, RMB89,235 and RMB50,970 with a related party for the years ended December 31, 2022, 2023 and 2024, respectively) | 336,163 | 179,446 | 99,693 | 13,658 | ||||||||||||
| Cost of revenues (including RMB163,686, RMB62,597 and RMB33,652 resulting from related party sales for the years ended December 31, 2022, 2023 and 2024, respectively) | (245,970 | ) | (127,851 | ) | (69,702 | ) | (9,549 | ) | ||||||||
| Gross profit | 90,193 | 51,595 | 29,991 | 4,109 | ||||||||||||
| Selling and marketing expenses | (2,330 | ) | (1,717 | ) | (2,367 | ) | (324 | ) | ||||||||
| General and administrative expenses | (26,830 | ) | (18,176 | ) | (26,407 | ) | (3,618 | ) | ||||||||
| Research and development expenses | (45,847 | ) | (53,144 | ) | (55,862 | ) | (7,653 | ) | ||||||||
| Total operating expenses | (75,007 | ) | (73,037 | ) | (84,636 | ) | (11,595 | ) | ||||||||
| Operating income/(loss) | 15,186 | (21,442 | ) | (54,645 | ) | (7,486 | ) | |||||||||
| Interest income | 7,501 | 9,043 | 6,644 | 910 | ||||||||||||
| Interest expenses | (46 | ) | (31 | ) | (64 | ) | (9 | ) | ||||||||
| Other income, net | 5,674 | 5,411 | 7,349 | 1,007 | ||||||||||||
| Income/(loss) before income tax expenses | 28,315 | (7,019 | ) | (40,716 | ) | (5,578 | ) | |||||||||
| Income tax (expenses)/benefits | (3,228 | ) | 6,463 | 1,852 | 254 | |||||||||||
| Net income/(loss) | 25,087 | (556 | ) | (38,864 | ) | (5,324 | ) | |||||||||
| Net income/(loss) per share | ||||||||||||||||
| Basic and diluted | 0.083 | (0.002 | ) | (0.128 | ) | (0.018 | ) | |||||||||
The accompanying notes are an integral part of these consolidated financial statements.
F-6
JIANGSU YITONG HIGH-TECH CO., LTD
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
| Ordinary Shares | Additional Paid-in | Accumulated Retained | Total Jiangsu Yitong Shareholders’ | Noncontrolling | Total Shareholders’ | |||||||||||||||||||||||
| Shares | Amount | Capital | Earnings | Equity | Interest | Equity | ||||||||||||||||||||||
| As of January 1, 2022 (Unaudited) | 302,675,973 | 302,676 | 39,955 | 144,427 | 487,058 | — | 487,058 | |||||||||||||||||||||
| Net income | — | — | — | 25,087 | 25,087 | — | 25,087 | |||||||||||||||||||||
| Share-based compensation | — | — | 9,228 | — | 9,228 | — | 9,228 | |||||||||||||||||||||
| Dividend distribution | — | — | — | (4,237 | ) | (4,237 | ) | — | (4,237 | ) | ||||||||||||||||||
| As of December 31, 2022 (Unaudited) | 302,675,973 | 302,676 | 49,183 | 165,277 | 517,136 | — | 517,136 | |||||||||||||||||||||
| Capital contribution | 1,231,250 | 1,231 | 6,134 | — | 7,365 | — | 7,365 | |||||||||||||||||||||
| Net loss | — | — | — | (556 | ) | (556 | ) | — | (556 | ) | ||||||||||||||||||
| Share-based compensation | — | — | (838 | ) | — | (838 | ) | — | (838 | ) | ||||||||||||||||||
| Dividend distribution | — | — | — | (2,730 | ) | (2,730 | ) | — | (2,730 | ) | ||||||||||||||||||
| As of December 31, 2023 | 303,907,223 | 303,907 | 54,479 | 161,991 | 520,377 | — | 520,377 | |||||||||||||||||||||
| Capital contribution | 22,500 | 23 | 134 | — | 157 | — | 157 | |||||||||||||||||||||
| Net (loss)/income | — | — | — | (38,864 | ) | (38,864 | ) | 17,640 | (21,224 | ) | ||||||||||||||||||
| Share-based compensation | — | — | (2,014 | ) | — | (2,014 | ) | — | (2,014 | ) | ||||||||||||||||||
| Other contribution | — | — | 2,946 | — | 2,946 | — | 2,946 | |||||||||||||||||||||
| As of December 31, 2024 | 303,929,723 | 303,930 | 55,545 | 123,127 | 482,602 | 17,640 | 500,242 | |||||||||||||||||||||
The accompanying notes are an integral part of these consolidated financial statements.
F-7
JIANGSU YITONG HIGH-TECH CO., LTD
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
| For the year ended December 31, | ||||||||||||||||
| 2022 (Unaudited) | 2023 | 2024 | 2024 | |||||||||||||
| RMB | RMB | RMB | US$ Note2 | |||||||||||||
| Cash Flows from Operating Activities | ||||||||||||||||
| Net income/(loss) | 25,087 | (556 | ) | (38,864 | ) | (5,324 | ) | |||||||||
| Adjustments to reconcile net income/(loss) to net cash provided by operating activities: | ||||||||||||||||
| Non-cash lease expenses | 654 | 560 | 816 | 112 | ||||||||||||
| Depreciation and amortization | 12,127 | 17,442 | 20,314 | 2,783 | ||||||||||||
| Provision for excess and obsolete inventories | 601 | 803 | 1,201 | 165 | ||||||||||||
| Gain on disposal of property, plant and equipment and others | (17 | ) | (21 | ) | (94 | ) | (13 | ) | ||||||||
| Share-based compensation | 9,228 | (838 | ) | (2,014 | ) | (276 | ) | |||||||||
| Deferred income taxes | (86 | ) | (8,738 | ) | (2,042 | ) | (280 | ) | ||||||||
| Expected credit loss | (748 | ) | (325 | ) | 7,388 | 1,012 | ||||||||||
| Impairment of contract assets | (390 | ) | (141 | ) | 338 | 46 | ||||||||||
| Impairment of property, plant and equipment | - | - | 620 | 85 | ||||||||||||
| Impairment of other non-current assets | - | - | 121 | 17 | ||||||||||||
| Changes in operating assets and liabilities: | ||||||||||||||||
| Notes receivable | 409 | 1,342 | (461 | ) | (63 | ) | ||||||||||
| Accounts receivable | (97 | ) | 9,016 | (105,234 | ) | (14,417 | ) | |||||||||
| Contract assets | 1,313 | 2,814 | (6,537 | ) | (896 | ) | ||||||||||
| Amounts due from related parties | 40,483 | 26,023 | (6,520 | ) | (893 | ) | ||||||||||
| Inventories, net | (12,462 | ) | 23,830 | (5,448 | ) | (746 | ) | |||||||||
| Installment receivables, net - current | (4,484 | ) | (11,304 | ) | (11,520 | ) | (1,578 | ) | ||||||||
| Prepayments and other current assets | 2,837 | (3,330 | ) | (10,919 | ) | (1,496 | ) | |||||||||
| Non-current installment receivable | (11,183 | ) | (2,752 | ) | 17,012 | 2,331 | ||||||||||
| Other non-current assets | - | - | (4,225 | ) | (579 | ) | ||||||||||
| Notes payable | (946 | ) | (3,900 | ) | (3,749 | ) | (514 | ) | ||||||||
| Accounts payable | (53,121 | ) | (16,196 | ) | 34,236 | 4,690 | ||||||||||
| Advance from customers | (3,022 | ) | (2,403 | ) | 623 | 85 | ||||||||||
| Income tax payable | 1,535 | (911 | ) | 2,814 | 386 | |||||||||||
| Accrued expenses and other current liabilities | 15 | (1,787 | ) | 21,169 | 2,900 | |||||||||||
| Amount due to related parties | 846 | 10,386 | 27,713 | 3,797 | ||||||||||||
| Deferred revenue | 1,100 | 3,286 | (727 | ) | (100 | ) | ||||||||||
| Other non-current liabilities | - | - | 736 | 101 | ||||||||||||
| Net Cash provided by/(used in) Operating Activities | 9,679 | 42,300 | (63,253 | ) | (8,665 | ) | ||||||||||
F-8
JIANGSU YITONG HIGH-TECH CO., LTD
CONSOLIDATED STATEMENTS OF CASH FLOWS – CONTINUED
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
| For the year ended December 31, | ||||||||||||||||
| 2022
(Unaudited) | 2023 | 2024 | 2024 | |||||||||||||
| RMB | RMB | RMB | US$ Note2 | |||||||||||||
| Cash Flows from Investing Activities | ||||||||||||||||
| Purchase of property and equipment and intangible assets | (12,222 | ) | (7,166 | ) | (24,323 | ) | (3,332 | ) | ||||||||
| Proceeds from disposal of property and equipment | 19 | 14 | 608 | 83 | ||||||||||||
| Proceeds from investment income | 315 | - | 473 | 65 | ||||||||||||
| Net cash paid for acquisition of subsidiary | - | - | (17,501 | ) | (2,398 | ) | ||||||||||
| Net Cash used in Investing Activities | (11,888 | ) | (7,152 | ) | (40,743 | ) | (5,582 | ) | ||||||||
| Cash Flows from Financing Activities | ||||||||||||||||
| Capital contribution | 4,093 | 3,272 | 157 | 22 | ||||||||||||
| Dividend distribution | (4,237 | ) | (2,730 | ) | - | - | ||||||||||
| Net Cash (used in)/ provided by Financing Activities | (144 | ) | 542 | 157 | 22 | |||||||||||
| Effects of exchange rate changes on cash and cash equivalents and restricted cash | (676 | ) | 767 | 546 | 74 | |||||||||||
| Net increase/ (decrease) in cash, cash equivalents and restricted cash | (3,029 | ) | 36,457 | (103,293 | ) | (14,151 | ) | |||||||||
| Cash, cash equivalents and restricted cash at beginning of the year | 300,488 | 297,459 | 333,916 | 45,746 | ||||||||||||
| Cash, cash equivalents and restricted cash at end of the year | 297,459 | 333,916 | 230,623 | 31,595 | ||||||||||||
| Reconciliation of cash and restricted cash | ||||||||||||||||
| Cash and cash equivalents | 293,906 | 331,532 | 229,364 | 31,423 | ||||||||||||
| Restricted cash | 3,553 | 2,384 | 1,259 | 172 | ||||||||||||
| Total cash, cash equivalents and restricted cash | 297,459 | 333,916 | 230,623 | 31,595 | ||||||||||||
| Supplemental disclosure of cash flow information | ||||||||||||||||
| Interest paid | 63 | 45 | - | - | ||||||||||||
| Income tax paid | 2,394 | 2,377 | 1,766 | 242 | ||||||||||||
| Non-cash investing activities | ||||||||||||||||
| Acquisition of intangible assets in amounts due to a related party | - | 19,748 | - | - | ||||||||||||
The accompanying notes are an integral part of these consolidated financial statements.
F-9
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 1 — ORGANIZATION AND BUSINESS DESCRIPTION
Jiangsu Yitong High-tech Co., Ltd (“the Company”, formerly known as Jiangsu Yitong Electronics Co., Ltd) is a company with limited liability incorporated under the laws of the People’s Republic of China (the “PRC” or the “China”) in November 1999.
The Company’s shares have been listed in Shenzhen Stock Exchange since May 2011 (“the Listing”).
On January 5, 2021, the controlling shareholder entered the agreement with Anhui Shunyuan Xinke Management Consulting Partnership (Limited Partnership) (“Anhui Shunyuan”) to transfer 29.99% equity interest of the Company with an aggregate cash consideration of RMB959.7 million. Anhui Shunyuan is a subsidiary of Zepp Health Corporation (“Zepp”). In May 2022, Anhui Shunyuan acquired another 0.01% equity interest of the Company through Stock Exchange Trading System. After the transaction, Anhui Shunyuan accounted for 30.0% equity interest of the Company. As of December 31, 2023 and 2024, Anhui Shunyuan accounted for 29.88% equity interest of the Company, respectively.
The Company and its subsidiaries (together “the Group”) are primarily engaged in the business of developing, manufacturing and sells of cable television network equipment, providing services to intelligent video monitoring engineering and developing, designing and sells of chips and sensors.
Zepp accounted for its investment in the Group using the equity method. As the Group is considered to be a significant equity method investee of Zepp for the fiscal year of 2024, its financial statements are included as an exhibit to the Annual Report of Zepp on Form 20-F in accordance with Securities and Exchange Commission (“SEC”) Rule 3-09 of Regulation S-X.
As of December 31, 2024, details of the Group’s major subsidiaries were as follows:
| Name | Place of incorporation | Date of Incorporation/ acquisition | Percentage of ownership | |||||||
| Suzhou Yiyitong Electronic Information Technology Co., Ltd (“Suzhou Yiyitong”) | PRC | September 25, 2020 | 100 | % | ||||||
| Whale Microelectronics Co., Ltd (“Whale Microelectronics”) | PRC | February 7, 2021 | 100 | % | ||||||
| Hefei Yunxi Medical Equipment Co., Ltd (“Hefei Yunxi”) | PRC | December 31, 2024 | 51 | % | ||||||
F-10
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Principles of consolidation
The consolidated financial statements include the financial statements of the Group and its wholly-owned subsidiaries. All transactions and balances between the Group and its subsidiaries have been eliminated upon consolidation.
Use of estimates
In preparing the consolidated financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, the assessment of the allowance for doubtful accounts, inventory valuation, useful lives of property and equipment and intangible assets, impairment of long-lived assets, purchase price allocations for business combination, uncertain tax position and valuation allowance for deferred tax assets. Actual results could differ from those estimates.
Fair value
Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Group considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability.
Authoritative literature provides a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The level in the hierarchy within which the fair value measurement in its entirety falls is based upon the lowest level of input that is significant to the fair value measurement as follows:
Level 1
Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
Level 2
Level 2 applies to assets or liabilities for which there are inputs other than quoted prices included within Level 1 that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
F-11
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Fair value - continued
Level 3
Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
The Group’s financial instruments consist primarily of cash and cash equivalents, restricted cash, accounts receivable, amounts due from a related party, installment payment receivables, notes payable, accounts payable, and amounts due to related parties. The carrying amounts of current portion of these financial instruments approximates their fair values due to the short-term maturities of these instruments.
The non-financial assets, such as property and equipment would be measured at FV as they were determined to be impaired.
Cash and cash equivalents
Cash and cash equivalents consist of cash on hand and demand deposits placed with commercial banks with an original maturity of three months or less, which are unrestricted from withdrawal or use, or which have original maturities of three months or less when purchases. The Group maintains all of the bank accounts in mainland China.
Restricted cash
Restricted cash consists of guarantee and deposits made to the bank for bank acceptance notes (or notes payable) issued by the Group. When the Group issues the bank acceptance notes, the banks require the Group to make a deposit for 30% of the face value of the bank acceptance notes issued as collateral. The deposits for unsettled bank acceptance notes were recorded as restricted cash in the consolidated balance sheets as of December 31, 2023 and 2024.
Accounts receivable
Accounts receivables represent those receivables derived in the ordinary course of business, net of allowance for doubtful accounts.
Allowance for doubtful accounts
The Group maintains an allowance for doubtful accounts for estimated losses on uncollected accounts receivable. Management considers the following factors when determining the collectability of specific accounts: creditworthiness of customers, aging of the receivables, past transaction history with customers and their current condition, changes in customer payment terms, specific facts and circumstances, and the overall economic climate in the industries the Group serves. The Group evaluates its receivable for expected credit losses on a regular basis. The Group maintains an estimated allowance for credit loss to reduce its receivables to the amount that it believes will be collected. The Group uses the creditworthiness of customers, aging of the receivables, past transaction history with customers and their current condition, changes in customer payment terms, specific facts and circumstances, and the overall economic climate in the industries the Group serves to monitor the Group’s receivables within the scope of expected credit losses model and use these as a basis to develop the Group’s expected loss estimates. As of December 31, 2023 and 2024, the Group had RMB3,884 and RMB8,945 allowance for doubtful account recorded in accounts receivable.
F-12
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Inventories, net
Inventories of the Group consist of raw materials, finished goods, work in process and inventoried costs relating to long-term contracts. Inventories are stated at the lower of cost or net realizable value on a weighted average basis. Inventory costs include expenses that are directly or indirectly incurred in the purchase, including shipping and handling costs charged to the Group by suppliers, and production of manufactured product for sale, such as include the cost of materials and supplies used in production, direct labor costs and allocated overhead costs such as depreciation, insurance, employee benefits, and indirect labor. Cost is determined using the weighted average method. The Group assesses the valuation of inventory and periodically writes down and writes off the value for estimated excess and obsolete inventory based upon the product life cycle.
Installment payment receivables, net
Installment receivables consist of receivables in relation to installment receivables resulting from engineering services provided by the Group. Installment receivables is recorded upon the revenue recognized and consists net of the unearned interest income and allowance for doubtful accounts. It is recognized as current or non-current assets in the balance sheets based on the remaining collection terms.
Property, plant and equipment, net
Property and equipment are carried at cost, net of accumulated depreciation and impairment, if any. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. Expenditures for repairs and maintenance, which do not materially extend the useful lives of the assets, are expensed as incurred. Expenditures for major renewals and betterments which substantially extend the useful life of assets are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation and amortization are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.
Estimated useful lives are as follows:
| Building | 5-30 years |
| Machinery and equipment | 1.75-10 years |
| Vehicles | 5 years |
| Office equipment | 5 years |
Intangible assets, net
Intangible assets purchased from third parties and related parties are initially recorded at cost and amortized on a straight-line basis over their estimated economic useful lives. Estimated useful lives are as follows:
| Land use right | 46-50 years | |
| Patent | 10 years | |
| Software | 5-10 years | |
| Franchise | 3-5 years | |
| Non-patent technology | 5 years |
F-13
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – CONTINUED
Business combination
Business combinations are recorded using the acquisition method of accounting. The assets acquired, the liabilities assumed, any non-controlling interests of the acquiree as well as the contingent consideration at the acquisition date, if any, are measured at their fair values as of the acquisition date. Goodwill is recognized and measured as the excess of the total consideration transferred plus the fair value of any non-controlling interest of the acquiree and fair value of previously held equity interest in the acquiree, if any, at the acquisition date over the fair values of the identifiable net assets acquired. The determination and allocation of fair values to the identifiable net assets acquired and liabilities assumed is based on various assumptions and valuation methodologies requiring considerable judgment from management. Although the Group believes that the assumptions applied in the determination are reasonable based on information available at the date of acquisition, actual results may differ from forecasted amounts and the differences could be material.
Goodwill
Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combination. The Group’s goodwill at December 31, 2024 was related to its acquisition of Hefei Yunxi in December 2024. In accordance with ASC 350, Goodwill and Other Intangible Assets, recorded goodwill amount is not amortized but is tested for impairment annually or more frequently if events on changes in circumstance indicate that it might be impaired.
Goodwill is tested for impairment at the reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. These events or circumstances could include a significant change in the stock prices, business climate, legal factors, operating performance indicators, competition, or sale or disposition of a significant portion of a reporting unit.
Application of the goodwill impairment test requires judgment, including the identification of reporting units, assignment of assets and liabilities to reporting units, assignment of goodwill to reporting units, and determination of the fair value of each reporting unit. The estimation of fair value of each reporting unit using a discounted cash flow methodology also requires significant judgments, including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for the Group’s business, estimation of the useful life over which cash flows will occur and determination of the Group’s weighted average cost of capital. The estimates used to calculate the fair value of a reporting unit change from year to year based on operating results and market conditions. Changes in these estimates and assumptions could materially affect the determination of fair value and goodwill impairment for the reporting unit.
Revenue recognition
The Group’s revenues are derived principally from developing, manufacturing and sells of broadcasting and television equipment, providing services to intelligent video monitoring engineer and developing and sells of chips and sensors. Value added taxes (“VAT”) are presented as a reduction of revenues.
F-14
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Revenue recognition – Continued
Revenue recognition on product sales
For all products sales, the Group requires a contract or purchase order which quantifies pricing, quantity and product specifications. The Group’s sales arrangements generally do not contain variable considerations and are short-term in nature. The Group recognizes revenue at a point in time when the customer obtains control of the products. Revenue is recognized as performance obligation under the terms of a contract with the customer are satisfied and control of the product has been transferred to the customer. Sales of goods do not include multiple products and/or service elements.
Revenue from engineering services and others
The Group provides intelligent video monitoring engineering services to customers and revenue of engineering services is recognized over time by measuring the progress towards complete satisfaction of that performance obligation. The progress towards complete satisfaction of the performance obligation is measured based on the Group’s efforts or inputs to the satisfaction of the performance obligation, by reference to the contracts cost incurred up to the end of reporting period as a percentage of total estimated costs for each contract. The Group also generates other revenue from repairment and rental services, which are immaterial.
Cost of revenue
Cost of revenues consists primarily of material costs, salaries and benefits for staff engaged in production and engineering activities, depreciation and amortization, outsourced services and related expenses which are directly attributable to the production of products. The shipping and handling fees billed to the customers are presented as part of cost of revenues as well.
Selling and marketing expenses
Selling and marketing expenses consist primarily of promotion and advertising expenses, staff costs and other daily expenses which are related to the selling and marketing departments. These expenses are charged to the consolidated statement of operations as incurred.
General and administrative expenses
General and administrative expenses consist primarily of salaries and welfare expenses and related expenses for employees involved in general corporate functions, including accounting, legal and human resources; and costs associated with use by these functions of facilities and equipment, such as traveling and general expenses, professional service fees and other related expenses. These expenses are charged to the consolidated statement of operations as incurred.
Research and development expenses
Research and development expenses consist primarily of salaries and benefits for research and development personnel, materials, office expenses, amortization and depreciation expenses associated with research and development activities.
F-15
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Income taxes
Income taxes are provided for in accordance with the laws of the relevant tax authorities. Deferred tax assets and liabilities are recognized when temporary differences exist between the tax bases of assets and liabilities and their reported amounts in the consolidated financial statements. Net operating loss carry forwards and credits are applied using enacted statutory tax rates applicable to future years. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more-likely-than-not that a portion of or all of the deferred tax assets will not be realized.
The Group accounts for uncertain tax positions by reporting a liability for unrecognized tax benefits resulting from uncertain tax positions taken or expected to be taken in a tax return. Tax benefits are recognized from uncertain tax positions when the Group believes that it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The Group recognizes interest and penalties, if any, related to unrecognized tax benefits in income tax expenses.
Value added tax (“VAT”)
The Group’s PRC subsidiaries are subject to value added tax (“VAT”) and related surcharges based on gross sales or service price depending on the type of services provided in the PRC (“output VAT”), and the VAT may be offset by VAT paid by the Group on service purchases (“input VAT”). The applicable rate of output VAT or input VAT for the Group is 2%, 5%, 6%, 9% and 13%. Gross sales or service price charged to customers is subject to output VAT at the rate and subsequently paid to PRC tax authorities after netting input VAT on purchases incurred during the period. The Group’s revenues are presented net of VAT collected on behalf of PRC tax authorities and its related surcharges; the VAT is not included in the consolidated statements of operations. All of the VAT returns filed by the Group’s subsidiaries in the PRC, have been and remain subject to examination by the tax authorities for five years from the date of filing.
Share-based payment
Share-based payment transactions with employees are measured based on the grant date value of the equity instrument. The Group that grants awards with graded, that is with multiple, vesting dates elect to recognize the awards on a straight-line basis as if it were several separate awards. The requisite service period is generally the vesting period of the award. The Group elects to recognize forfeitures then they occur.
Foreign currencies
The reporting currency of the Group is RMB. The Group’s principal country of operations is the PRC. The financial position and results of its operations are determined using the RMB, the local currency, as the functional currency.
Convenience translation
Translations of balances in the consolidated balance sheets, consolidated statements of operations and consolidated statements of cash flows from RMB into US$ as of and during the year ended December 31, 2024 is solely for the convenience of the reader and were calculated at the rate of US$1.00 = RMB7.2993, representing the rate as certified by the statistical release of the Federal Reserve Board of United States on December 31, 2024. No representation is made that the RMB amounts could have been, or could be, converted, realized or settled into U.S. dollar at that rate on December 31, 2024, or at any other rate.
F-16
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Net income (loss) per share
Basic net income (loss) per ordinary share is computed by dividing net income (loss) attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.
Diluted income per ordinary share reflects the potential dilution that would occur if securities were exercised or converted into ordinary shares. The Group had restricted shares which could potentially dilute basic income per ordinary share in the future. To calculate the number of shares for diluted income per ordinary shares, the effect of the restricted shares is computed using the treasury stock method.
Concentration of credit risk
Financial instruments that potentially expose the Group to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable. The Group places its cash and cash equivalents with financial institutions with high credit ratings and quality.
The Group conducts credit evaluations of third-party customers and related parties, and generally does not require collateral or other security from its third-party customers and related parties. The Group establishes an allowance for doubtful accounts primarily based upon the age of the receivables and factors surrounding the credit risk of specific third-party customers and related parties.
Major Customers
Accounts receivable concentration of credit risk is as below:
| As of December 31, | ||||||||||||||||
| 2023 | 2024 | |||||||||||||||
| RMB | RMB | |||||||||||||||
| Company A | - | - | 48,956 | 40.3 | % | |||||||||||
| Company B | - | - | 24,844 | 20.4 | % | |||||||||||
| Company C | - | - | 17,538 | 14.4 | % | |||||||||||
| Company D | 3,577 | 16.8 | % | 4,205 | 3.5 | % | ||||||||||
| Company E | 2,400 | 11.3 | % | 1,331 | 1.1 | % | ||||||||||
| Total | 5,977 | 28.1 | % | 96,874 | 79.7 | % | ||||||||||
F-17
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Concentration of credit risk – Continued
Major Customers - continued
Amounts due from related parties’ concentration of credit risk is as below:
| As of December 31, | ||||||||||||||||
| 2023 | 2024 | |||||||||||||||
| RMB | RMB | |||||||||||||||
| Company F | 11,660 | 98.8 | % | 18,182 | 99.3 | % | ||||||||||
| Total | 11,660 | 98.8 | % | 18,182 | 99.3 | % | ||||||||||
Revenue concentration of credit risk is as below:
| For the years ended December 31, | ||||||||||||||||||||||||
| 2022 (Unaudited) | 2023 | 2024 | ||||||||||||||||||||||
| RMB | RMB | RMB | ||||||||||||||||||||||
| Company F | 222,174 | 66.1 | % | 89,235 | 49.7 | % | 50,970 | 51.1 | % | |||||||||||||||
| Total | 222,174 | 66.1 | % | 89,235 | 49.7 | % | 50,970 | 51.1 | % | |||||||||||||||
Major Suppliers
Accounts payable concentration of credit risk is as below:
| As of December 31, | ||||||||||||||||
| 2023 | 2024 | |||||||||||||||
| RMB | RMB | |||||||||||||||
| Company G | - | - | 6,782 | 13.8 | % | |||||||||||
| Company H | - | - | 6,555 | 13.4 | % | |||||||||||
| Company I | 1,757 | 11.8 | % | 3,269 | 6.7 | % | ||||||||||
| Total | 1,757 | 11.8 | % | 16,606 | 33.9 | % | ||||||||||
F-18
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - CONTINUED
Concentration of credit risk – Continued
Major Suppliers – continued
Amounts due to related parties, current and non-current concentration of credit risk is as below:
| As of December 31, | ||||||||||||||||
| 2023 | 2024 | |||||||||||||||
| RMB | RMB | |||||||||||||||
| Company J | - | - | 24,656 | 56.1 | % | |||||||||||
| Company K | 19,748 | 63.4 | % | 12,068 | 27.4 | % | ||||||||||
| Company F | 10,681 | 34.3 | % | 7,018 | 16.0 | % | ||||||||||
| Total | 30,429 | 97.7 | % | 43,742 | 99.5 | % | ||||||||||
Purchase concentration of credit risk is as below:
| For the years ended December 31, | ||||||||||||||||||||||||
| 2022 (Unaudited) | 2023 | 2024 | ||||||||||||||||||||||
| RMB | RMB | RMB | ||||||||||||||||||||||
| Company L | - | - | - | - | 11,736 | 13.8 | % | |||||||||||||||||
| Company I | 25,298 | 10.3 | % | 12,812 | 15.2 | % | 5,531 | 6.5 | % | |||||||||||||||
| Company M | 24,761 | 10.1 | % | 7,561 | 8.9 | % | 2,164 | 2.5 | % | |||||||||||||||
| Company N | 30,246 | 12.4 | % | 6,084 | 7.2 | % | 2,064 | 2.4 | % | |||||||||||||||
| Total | 80,305 | 32.8 | % | 26,457 | 31.3 | % | 21,495 | 25.2 | % | |||||||||||||||
Recent accounting pronouncements
In November 2024, the FASB issued ASU No. 2024-03, which requires disaggregated disclosure of income statement expenses for public business entities (PBEs). The ASU does not change the expense captions an entity presents on the face of the income statement; rather, it requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. The guidance is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Adoption of this guidance should be applied retrospectively to all prior periods presented. Early adoption is permitted. The Group is currently in the process of evaluating the disclosure impact of adopting ASU 2024-03.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280)- Improvements to Reportable Segment Disclosures. ASU No. 2023-07 requires an enhanced disclosure of significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, on an annual and interim basis. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Adoption of this guidance should be applied retrospectively to all prior periods presented. Early adoption is permitted. The adoption of this guidance did not have a material impact on its consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740)- Improvements to Income Tax Disclosures. ASU No. 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional information on income taxes paid. The guidance is effective for annual periods beginning after December 15, 2024 on a prospective basis. Early adoption is permitted. The Group is currently in the process of evaluating the disclosure impact of adopting ASU 2023-09.
F-19
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 3 — INVENTORIES, NET
Inventories, net consisted of the following:
| As of December 31, | ||||||||
| 2023 | 2024 | |||||||
| RMB | RMB | |||||||
| Raw materials | 2,718 | 654 | ||||||
| Work in progress | 3,927 | 11,465 | ||||||
| Finished goods | 10,753 | 9,585 | ||||||
| Inventoried costs relating to long-term contracts | 748 | 1,322 | ||||||
| Inventories, net | 18,146 | 23,026 | ||||||
During the years ended December 31, 2022, 2023 and 2024, the Group recorded a provision for the excess and obsolete inventories amounting to RMB601, RMB803 and RMB1,201, respectively.
NOTE 4 — INSTALLMENT RECEIVABLES, NET
Installment receivables relating to the installment for engineering services consisted of the following:
| As of December 31, | ||||||||
| 2023 | 2024 | |||||||
| RMB | RMB | |||||||
| Current portion of Installment receivables | 24,698 | 36,218 | ||||||
| Noncurrent installment receivables | 41,455 | 24,443 | ||||||
| Allowance for doubtful accounts | (338 | ) | (5,085 | ) | ||||
| Total | 65,815 | 55,576 | ||||||
As of December 31, 2024, the due date of installment receivables is as follows:
| RMB | ||||
| 2025 | 40,029 | |||
| 2026 | 11,277 | |||
| 2027 | 11,723 | |||
| 2028 | 2,813 | |||
| 2029 | 192 | |||
| Total installment receivables | 66,034 | |||
| Less: Unrealized interest income | (5,373 | ) | ||
| Installment receivables, gross | 60,661 | |||
| Less: Allowance for installment receivables | (5,085 | ) | ||
| Installment receivables, net | 55,576 | |||
F-20
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 5 — PROPERTY, PLANT AND EQUIPMENT, NET
Property, plant and equipment, net consisted of the following:
| As of December 31, | ||||||||
| 2023 | 2024 | |||||||
| RMB | RMB | |||||||
| Buildings | 121,591 | 121,224 | ||||||
| Machinery and equipment | 166,775 | 157,901 | ||||||
| Office equipment | 7,481 | 6,688 | ||||||
| Vehicles | 5,767 | 6,102 | ||||||
| 301,614 | 291,915 | |||||||
| Less: accumulated depreciation and impairment | (217,814 | ) | (217,745 | ) | ||||
| Construction in progress | 252 | - | ||||||
| Property, plant and equipment, net | 84,052 | 74,170 | ||||||
The Group has recorded depreciation expenses of RMB8,986, RMB11,223 and RMB9,362 during the years ended December 31, 2022, 2023 and 2024, respectively. Impairment of nil, nil and RMB608 was recorded during the years ended December 31, 2022, 2023 and 2024.
NOTE 6 — INTANGIBLE ASSETS, NET
Intangible assets, net consisted of the following:
| As of December 31, | ||||||||
| 2023 | 2024 | |||||||
| RMB | RMB | |||||||
| Land use right | 14,599 | 14,599 | ||||||
| Patent | 4,584 | 4,584 | ||||||
| Software | 8,187 | 10,161 | ||||||
| Franchise | 17,414 | 31,428 | ||||||
| Non-patent technology | 20,700 | 20,700 | ||||||
| 65,484 | 81,472 | |||||||
| Less: accumulated amortization | (24,784 | ) | (35,737 | ) | ||||
| Intangible assets, net | 40,700 | 45,735 | ||||||
Amortization expenses for the intangible assets for the years ended December 31, 2022, 2023 and 2024, were RMB3,071, RMB6,219 and RMB10,952, respectively. Future amortization expenses relating to the existing intangible assets amounted to RMB14,415 for the next year, RMB12,131 for the second year, RMB6,235 for the third year, RMB3,895 for the fourth year, RMB809 for the fifth year and RMB8,250 thereafter.
F-21
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 7 – BUSINESS COMBINATION
In November 2024, the Company entered into an equity transfer agreement with Hefei Yunxi Medical Equipment Co., Ltd. (“Hefei Yunxi”) and its original shareholders to acquire 51% equity interest at a cash consideration of RMB18,360. Hefei Yunxi primarily engages in the business of selling medical equipment in PRC. According to the equity transfer agreement, the Group owns the right to request the transferer making the performance commitment for the three years following acquisition. On December 31, 2024, the Company completed the acquirement 51% equity interest in Hefei Yunxi. Upon completion of the transaction, Hefei Yunxi became a consolidated subsidiary of the Group.
The Group engaged an independent valuation firm to assist management in valuing assets acquired, liabilities assumed, contingent consideration and non-controlling interests as of acquisition day.
The allocation of the purchase price as of the date of acquisition is summarized as follows:
| Fair value of consideration | 18,360 | |||
| Recognized amounts of identifiable assets acquired and liability assumed: | ||||
| Total assets | 56,274 | |||
| Total liabilities | (51,228 | ) | ||
| Total identifiable net assets (i) | 5,046 | |||
| Noncontrolling interest (ii) | 17,640 | |||
| Goodwill | 30,954 |
i. All assets and liabilities carrying value approximately fair value at the time of acquisition.
ii. Noncontrolling interest was recognized and measured at fair value on the acquisition date by the Group.
NOTE 8 – GOODWILL
The changes in the carrying amount of goodwill are as follows:
| As of December 31, | ||||||||
| 2023 | 2024 | |||||||
| RMB | RMB | |||||||
| Balance at beginning of the year | - | - | ||||||
| Additions to goodwill | - | 30,954 | ||||||
| Balance at end of the year | - | 30,954 | ||||||
In addition, based on impairment assessment adopted as of December 31, 2024, no impairment has been noted.
F-22
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 9 — ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
| As of December 31, | ||||||||
| 2023 | 2024 | |||||||
| RMB | RMB | |||||||
| Accrued expenses | 601 | 9,788 | ||||||
| Accrued payroll and welfare | 6,281 | 6,536 | ||||||
| Capital contribution of restricted shares | 2,093 | - | ||||||
| Payable for research development fee | 2,153 | 3,224 | ||||||
| Other tax payables | 957 | 2,608 | ||||||
| Payable for intangible assets | - | 1,963 | ||||||
| Other payables | 1,058 | 1,936 | ||||||
| Total | 13,143 | 26,055 | ||||||
NOTE 10 — BANK BORROWING
In July 2023, Hefei Yunxi entered into a RMB10,000 three-year revolving facility agreement with Bank of China Hefei Branch. The facility is guaranteed by Hefei Yunxi’s non-controlling shareholders and collateralized by property owned by them. As of December 31, 2024, the total outstanding borrowing was RMB10,000, during which RMB1,103 are repayable within one year and are included in “Short-term bank borrowing” on the consolidated balance sheets.
NOTE 11 — RELATED PARTY TRANSACTIONS AND BALANCES
Nature of relationships with related parties:
| Name | Relationship with the Group | |
| Anhui Huami Information Technology Co., Ltd (“Anhui Huami”) | A company controlled by principal shareholder | |
| Hefei Huami Microelectronics Co., Ltd (“Hefei Huami”) | A company controlled by principal shareholder | |
| Mr. Tao Zhang | A person has a significant influence on subsidiary | |
| Anhui Xikai Medical Technology Co., Ltd (“Anhui Xikai”) | A company controlled by Mr. Tao Zhang |
F-23
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 11 — RELATED PARTY TRANSACTIONS AND BALANCES - CONTINUED
Transactions with related parties
| For the years ended December 31, | ||||||||||||
| 2022 (Unaudited) | 2023 | 2024 | ||||||||||
| RMB | RMB | RMB | ||||||||||
| Sales to a related party | ||||||||||||
| Anhui Huami | 222,174 | 89,235 | 60,012 | |||||||||
| Research development services provided by a related party | ||||||||||||
| Anhui Huami (a) | 2,337 | 10,460 | 6,815 | |||||||||
| Intangible assets purchased from a related party | ||||||||||||
| Hefei Huami (b) | — | 20,700 | — | |||||||||
Balances with related parties
As of December 31, 2023 and 2024, the balances with related parties were as follows:
| As of December 31, | ||||||||
| 2023 | 2024 | |||||||
| RMB | RMB | |||||||
| Amounts due from related parties | ||||||||
| Anhui Huami | 11,660 | 18,182 | ||||||
| Others | 138 | 136 | ||||||
| Total | 11,798 | 18,318 | ||||||
| Amounts due to related parties, current and non-current | ||||||||
| Anhui Xikai (c) | — | 24,656 | ||||||
| Hefei Huami (b) | 19,748 | 12,068 | ||||||
| Anhui Huami (a) | 10,681 | 7,018 | ||||||
| Others | 714 | 245 | ||||||
| Total | 31,143 | 43,987 | ||||||
| (a) | The amount due to Anhui Huami primarily represents the payable in relation to the research and development supporting services provided by Anhui Huami. |
| (b) | The amount due to Hefei Huami primarily represents the payable in relation to the transfer of certain intangible assets from Hefei Huami for a total consideration of RMB21,942, including VAT, in which RMB2,194 and RMB7,680 were paid by the Group during 2023 and 2024, respectively. |
| (c) | The amount due to Anhui Xikai primarily represents the payable in relation to the expenses on behalf of the Group and goods purchased from Anhui Xikai. |
F-24
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 12 — REVENUE
Disaggregation of revenue
The following table summarized disaggregated revenue for the years ended December 31, 2022, 2023 and 2024:
| For the Years Ended December 31, | ||||||||||||
| 2022 (Unaudited) | 2023 | 2024 | ||||||||||
| RMB | RMB | RMB | ||||||||||
| Category of Revenue | ||||||||||||
| Revenue on product sales | 282,348 | 128,517 | 65,714 | |||||||||
| Revenue from engineering services and others | 53,815 | 50,929 | 33,979 | |||||||||
| 336,163 | 179,446 | 99,693 | ||||||||||
Contract balances
The following table provides information about receivables, contract assets, installment payment receivables and advance from customers from contracts with customers:
| As of December 31, | ||||||||
| 2023 | 2024 | |||||||
| RMB | RMB | |||||||
| Accounts receivables | 21,315 | 121,488 | ||||||
| Amounts due from a related party | 11,576 | 18,182 | ||||||
| Installment payment receivables, net, current portion | 24,360 | 33,189 | ||||||
| Contract assets | 399 | 6,598 | ||||||
| Noncurrent installment receivables | 41,455 | 22,387 | ||||||
| Advance from customers | 3,375 | 3,998 | ||||||
The Group recognizes accounts receivable, contracts assets, amounts due from a related party, installment receivables in its consolidated balance sheets when it performs a service in advance of receiving consideration and it has the unconditional right to receive consideration. Contract assets is unbilled amount related to the progress towards complete satisfaction under engineering services agreements. Payments received from customers are based on the payment terms established in its contracts. Such payments are initially recorded to advance from customers and are recognized into revenue as the Group satisfies its performance obligations. Substantially all of advance from customers will be recognized as revenue during the Group’s following fiscal year.
F-25
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 13 — INCOME TAXES
The Group are subject to the 25% standard enterprise income tax rate except for the Group and Whale Microelectronics that qualify as a high and new technology enterprise (“HNTE”), which are subject to a tax rate of 15%. The Group began to qualify as HNTE in 2020 and renewed the HNTE certificate in November 2023. Accordingly, the Group was subject to a tax rate of 15% during the year ended December 31, 2022, 2023 and 2024. Whale Microelectronics qualified as a HNTE in November 2023 and is subject to a tax rate of 15% during the years ended December 31, 2023 and 2024.
The provision for income tax consisted of the following:
| For the years ended December 31, | ||||||||||||
| 2022 (Unaudited) | 2023 | 2024 | ||||||||||
| RMB | RMB | RMB | ||||||||||
| Current income tax expense | 3,314 | 2,275 | 190 | |||||||||
| Deferred income tax benefit | (86 | ) | (8,738 | ) | (2,042 | ) | ||||||
| Income tax expenses/(benefit) | 3,228 | (6,463 | ) | (1,852 | ) | |||||||
The significant components of the Group’s deferred tax assets were as follows:
| As of December 31, | ||||||||
| 2023 | 2024 | |||||||
| RMB | RMB | |||||||
| Net operating loss carry forwards | 8,704 | 8,817 | ||||||
| Impairment of assets | 1,229 | 3,627 | ||||||
| Accrued expenses | - | 1,965 | ||||||
| Installment receivables | 788 | 763 | ||||||
| Deferred revenue | - | 549 | ||||||
| Others | 189 | 199 | ||||||
| Total deferred tax assets | 10,910 | 15,920 | ||||||
| Less: valuation allowance | - | - | ||||||
| Deferred tax assets, net | 10,910 | 15,920 | ||||||
F-26
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 13 — INCOME TAXES - CONTINUED
Reconciliation between the tax expense computed by applying the PRC enterprise tax rate of 25% to income/(loss) before income tax and the actual tax expense were as follows:
| For the years ended December 31, | ||||||||||||
| 2022 (Unaudited) | 2023 | 2024 | ||||||||||
| RMB | RMB | RMB | ||||||||||
| Income/(loss) before income tax | 28,315 | (7,019 | ) | (40,716 | ) | |||||||
| Tax expense/(benefit) at income tax rate of 25% | 7,079 | (1,755 | ) | (10,179 | ) | |||||||
| Effect of preferential tax rates | (1,936 | ) | 721 | 4,058 | ||||||||
| Non-deductible expenses | 3,016 | (369 | ) | (53 | ) | |||||||
| Additional deduction for R&D expenses | (4,931 | ) | (4,795 | ) | (5,505 | ) | ||||||
| Operating income offset loss carryforward | — | (265 | ) | 9,827 | ||||||||
| Income tax expenses/(benefit) | 3,228 | (6,463 | ) | (1,852 | ) | |||||||
If the Group did not enjoy the tax holidays, tax expense would have increased by RMB1,936 and decreased by RMB721 and RMB4,058 for the year ended December 31, 2022, 2023 and 2024, respectively. The (decrease)/increase in basic and diluted net income per ordinary share would be RMB(0.006), RMB0.002 and RMB0.013 for the year ended December 31, 2022, 2023 and 2024, respectively.
NOTE 14 — SHARE-BASED COMPENSATION
2021 Share Incentive Plan
In August 2021, the Group adopted the 2021 share incentive plan (the “2021 Plan”) that provides for grant of restricted shares to employees. The maximum aggregate number of shares which may be issued pursuant to all awards under the 2021 Plan is 4,243,750 shares. The 2021 Plan permits the awards of restricted shares. The restricted shares are not transferable and may not be sold or pledged and the holder has no voting or dividend right the non-vested shares. On February 28, 2022, the Group has amended the Plan so as to increase the number of shares to 220,000 in accordance with rules of the 2021 Plan.
During the years ended December 31, 2022, 2023 and 2024, the Group granted 220,000, nil and nil restricted shares to personnel under the 2021 Plan.
2022 Share Incentive Plan
On April 28, 2022, the Group adopted the 2022 share incentive plan (the “2022 Plan”). The maximum aggregate number of shares which may be issued pursuant to all awards under the 2022 Plan is 5,250,000 shares. The 2022 Plan permits the awards of restricted shares. For those awards, evaluations are made as of each reporting period to assess the likelihood of performance criteria being met. On November 24, 2022, the Group has amended the Plan so as to increase the number of shares to 150,000 in accordance with the rules of the 2022 Plan.
F-27
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 14 — SHARE-BASED COMPENSATION - CONTINUED
2022 Share Incentive Plan – Continued
During the years ended December 31, 2022, 2023 and 2024, the Group granted 4,350,000, nil and nil restricted shares to personnel under the 2022 Plan.
The Group calculated the estimated fair value of the restricted shares on the grant dates using the Black-Scholes option pricing model. Assumptions used to determine the fair value of restricted share granted during the year ended December 31, 2022 are summarized in the following table, no shares were granted in 2023 and 2024:
| 2022 (Unaudited) | ||||
| RMB | ||||
| Risk-free interest rate | 1.50-2.75 | % | ||
| Expected volatility | 19.70-25.18 | % | ||
| Expected life of share (years) | 1-4 | |||
| Expected dividend yield | 0.08 | % | ||
| Fair value per ordinary share | RMB0.64-5.83 | |||
| (i) | Risk-free interest rate |
Risk-free interest was estimated based on the yield to maturity of China international government bonds with a maturity period close to the contractual term of the shares.
| (ii) | Expected life of share (years) |
Expected life of option (years) represents the expected years to vest the restricted shares.
| (iii) | Volatility |
The volatility of the underlying restricted share during the life of the shares was estimated based on the historical stock price volatility of comparable listed companies over a period comparable to the contractual term of the shares.
| (iv) | Dividend yield |
The dividend yield was estimated by the Group based on its expected dividend policy over the contractual term of the restricted shares.
| (v) | Fair value of underlying restricted share |
During the years ended December 31, 2024, the fair value of the underlying restricted share was determined based on the Black-Scholes option pricing model of the shares.
F-28
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 14 — SHARE-BASED COMPENSATION - CONTINUED
A summary of the restricted shares activity during the year ended December 31, 2024 is presented below:
| Weighted average | ||||||||
| exercise price | ||||||||
| Number of shares | per share | |||||||
| US$ | ||||||||
| Outstanding at January 1, 2024 | 2,142,750 | 0.29 | ||||||
| Granted | — | — | ||||||
| Exercised | (22,500 | ) | — | |||||
| F Forfeited | (1,357,750 | ) | — | |||||
| Outstanding at December 31, 2024 | 762,500 | 0.96 | ||||||
The following table summarizes information regarding the restricted share as of December 31, 2024:
| December 31, 2024 | ||||||||||||||||
| Weighted | ||||||||||||||||
| average remaining | ||||||||||||||||
| Weighted | exercise | |||||||||||||||
| average exercise | contractual | Aggregate | ||||||||||||||
| Shares Number | price per share | life (years) | intrinsic value | |||||||||||||
| US$ | US$ | |||||||||||||||
| Shares | ||||||||||||||||
| Outstanding | 762,500 | 0.96 | 1.34 | 200,881 | ||||||||||||
| Exercisable | — | — | — | — | ||||||||||||
| Expected to vest | 762,500 | 0.96 | 1.34 | 200,881 | ||||||||||||
The total intrinsic value of restricted shares exercised during the years ended December 31, 2022, 2023 and 2024 amounted nil, RMB3,045 and RMB1,466, respectively.
The weighted average grant date fair value of restricted share granted during the year ended December 31, 2022, 2023 and 2024 was RMB0.95, nil and nil per share, respectively.
As of December 31, 2024, there was RMB178 of unrecognized compensation expenses related to the shares which will be recognized within two years.
F-29
JIANGSU YITONG HIGH-TECH CO., LTD
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Amounts in thousands of Renminbi (“RMB”) and U.S. dollars (“US$”)
except for number of shares and per share data, or otherwise noted)
NOTE 14 — SHARE-BASED COMPENSATION – CONTINUED
Total share-based compensation recognized during the years ended December 31, 2022, 2023 and 2024 was as follows:
| For the years ended December 31, |
||||||||||||
| 2022 (Unaudited) |
2023 | 2024 | ||||||||||
| RMB | RMB | RMB | ||||||||||
| Selling and marketing expenses | 234 | - | - | |||||||||
| General and administrative | 2,329 | 16 | (703 | ) | ||||||||
| Research and development | 6,665 | (854 | ) | (1,311 | ) | |||||||
| Total share-based compensation expenses | 9,228 | (838 | ) | (2,014 | ) | |||||||
NOTE 15 — ORDINARY SHARES
In 2024, the exercise of restricted share was 22,500 ordinary shares with the total amount of RMB157. As a result, the ordinary shares of the Group are 303,907,223 and 303,929,723 as of December 31, 2023 and 2024, respectively.
NOTE 16 — STATUTORY RESERVE
In accordance with the PRC Company Laws, the Group’s subsidiaries in the PRC are required to provide for statutory reserves, which are appropriated from net profit as reported in the Group’s PRC statutory accounts. They are required to allocate 10% of their after-tax profits to fund statutory reserves until such reserves have reached 50% of their respective registered capital. These reserve funds, however, may not be distributed as cash dividends. During the years ended December 31, 2022, 2023 and 2024, the Group accrued an additional RMB2,509, RMB1,396 and nil statutory reserve from the new appropriable profit earned by certain PRC entities.
F-30
| ITEM 19. | EXHIBITS |
* Filed with this Amendment No. 1 to Annual Report on Form 20-F.
** Furnished with this Amendment No. 1 to Annual Report on Form 20-F.
2
SIGNATURES
The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F, and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.
| Zepp Health Corporation | ||
| By: | /s/ Wang Wayne Huang | |
| Name: | Wang Wayne Huang | |
| Title: | Chairman of the Board of Directors and Chief Executive Officer | |
Date: May 21, 2025
3
Exhibit 12.1
Certification by the Principal Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Wang Wayne Huang, certify that:
| 1. | I have reviewed this annual report on Form 20-F of Zepp Health Corporation (the “Company”); |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; |
| 4. | The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have: |
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| (c) | Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| (d) | Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and |
| 5. | The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting. |
| Date: May 21, 2025 | ||
| By: | /s/ Wang Wayne Huang | |
| Name: | Wang Wayne Huang | |
| Title: | Chief Executive Officer | |
Exhibit 12.2
Certification by the Chief Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Leon Cheng Deng, certify that:
| 1. | I have reviewed this annual report on Form 20-F of Zepp Health Corporation (the “Company”); |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; |
| 4. | The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have: |
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| (c) | Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| (d) | Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and |
| 5. | The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting. |
| Date: May 21, 2025 | ||
| By: | /s/ Leon Cheng Deng | |
| Name: | Leon Cheng Deng | |
| Title: | Chief Financial Officer | |
Exhibit 13.1
Certification by the Principal Executive Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Zepp Health Corporation (the “Company”) on Form 20-F for the fiscal year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wang Wayne Huang, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: May 21, 2025 | ||
| By: | /s/ Wang Wayne Huang | |
| Name: | Wang Wayne Huang | |
| Title: | Chief Executive Officer | |
Exhibit 13.2
Certification by the Chief Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Zepp Health Corporation (the “Company”) on Form 20-F for the fiscal year ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Leon Cheng Deng, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: May 21, 2025 | ||
| By: | /s/ Leon Cheng Deng | |
| Name: | Leon Cheng Deng | |
| Title: | Chief Financial Officer | |
Exhibit 15.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 333-226665 and No. 333-269830 on Form S-8 of our report dated May 21, 2025, relating to the consolidated financial statements of Jiangsu Yitong High-tech Co., Ltd. included in this Amendment No. 1 to the Annual Report on Form 20-F for the year ended December 31, 2024.
| /s/ BROOK & PARTNERS CPAs | |
| Beijing, the People’s Republic of China |
May 21, 2025